Top Page
GenusPlus Group Ltd.
(Sydney:GNP)
GenusPlus Group Ltd. (GNP) vs. iShares MSCI Australia ETF (EWA)
GenusPlus Group Ltd. Business Overview & Revenue Model
GenusPlus Group Ltd. Financial Statement Overview
| Breakdown | |||||
| TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|---|
| Income Statement | Total Revenue | ||||
| 634.11M | 551.19M | 444.18M | 451.15M | 318.21M | 169.96M | Gross Profit |
| 490.27M | 400.06M | 43.54M | 311.85M | 221.55M | 21.02M | EBIT |
| 34.53M | 30.02M | 18.52M | 20.12M | 19.24M | 9.74M | EBITDA |
| 45.15M | 43.11M | 34.07M | 32.54M | 27.28M | 20.41M | Net Income Common Stockholders |
| 23.91M | 19.26M | 13.41M | 13.56M | 13.35M | 10.69M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
| 61.69M | 100.97M | 46.74M | 27.88M | 34.18M | 29.82M | Total Assets |
| 319.60M | 288.15M | 227.42M | 231.98M | 155.56M | 122.16M | Total Debt |
| 31.43M | 29.25M | 27.73M | 27.17M | 19.88M | 4.07M | Net Debt |
| -30.27M | -71.71M | -19.01M | -714.57K | -14.30M | -25.75M | Total Liabilities |
| 182.36M | 166.98M | 122.44M | 138.56M | 97.85M | 75.98M | Stockholders Equity |
| 137.24M | 121.17M | 104.98M | 93.42M | 57.71M | 46.18M |
| Cash Flow | Free Cash Flow | ||||
| 69.73M | 68.90M | 32.09M | 6.60M | -4.30M | 29.95M | Operating Cash Flow |
| 87.86M | 82.84M | 37.79M | 11.47M | 6.99M | 37.42M | Investing Cash Flow |
| -33.50M | -15.82M | -7.31M | -24.25M | -12.42M | -9.42M | Financing Cash Flow |
| -14.74M | -12.79M | -11.48M | 6.33M | -189.08K | 3.81M |
GenusPlus Group Ltd. Technical Analysis
GenusPlus Group Ltd. Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | AU$1.36B | 11.56 | 18.01% | 4.70% | 13.68% | 24.51% | |
73 Outperform | $415.82M | 8.93 | 36.14% | 1.11% | -1.31% | -18.79% | |
70 Neutral | AU$623.44M | 25.74 | 19.31% | 0.72% | 35.02% | 48.51% | |
68 Neutral | $10.83B | 8.55 | -1.44% | 6.51% | 8.15% | -103.96% | |
66 Neutral | $4.51B | 12.22 | 5.40% | 3.63% | 4.14% | -12.01% | |
65 Neutral | AU$4.16B | 57.31 | 3.35% | 3.48% | -7.32% | ― |
GenusPlus Group Ltd. Corporate Events
GenusPlus Group Ltd has secured a significant contract with NBN Co, valued at approximately $130 million, to upgrade the remaining Fibre to the Node network across Western Australia. This contract, which will be executed over 3.5 years, marks a strategic advancement in GenusPlus’s growth, reinforcing its position as a leading contractor in Australia’s critical infrastructure sector.
The most recent analyst rating on (AU:GNP) stock is a Buy with a A$2.70 price target. To see the full list of analyst forecasts on GenusPlus Group Ltd. stock, see the AU:GNP Stock Forecast page.
GenusPlus Group Ltd. announced a change in the director’s interest, specifically involving David William Riches. The transaction involved the disposal of 200,000 fully paid ordinary shares through an on-market trade, valued at $585,102. This change reflects a minor adjustment in the director’s indirect interest holdings, which may have implications for stakeholders monitoring insider trading activities.
GenusPlus Group Ltd. has announced a change in the director’s interest notice, specifically concerning David William Riches. The notice details a disposal of 600,000 fully paid ordinary shares by David William Riches and Matthew Steven Riches ATF Dave Riches and Matt Riches Unit Trust, with the transaction valued at $1,548,787. This change in shareholding, conducted through an on-market trade, reflects a minor adjustment in the director’s indirect interest in the company.
GenusPlus Group Ltd has completed the acquisition of MGC Group Holdings, marking its strategic entry into the rail systems sector, which offers significant growth potential. This acquisition allows GenusPlus to provide specialized rail systems services to Tier 1 customers in the metro, mining, and freight sectors in Western Australia, complementing its existing service divisions. The acquisition was funded through internal cash reserves and is expected to be immediately earnings accretive, enhancing GenusPlus’s market positioning in essential infrastructure services.
GenusPlus Group Ltd has announced a proposed issue of securities, with a maximum of 899,121 ordinary fully paid securities to be issued. This move is part of a placement or other type of issue, with the proposed issue date set for November 30, 2028. The announcement indicates a strategic effort by GenusPlus to potentially raise capital, which could impact its operations and market positioning by enhancing its financial resources for future growth and development.
GenusPlus Group Ltd has announced the issuance of 852,454 performance rights set to expire on July 1, 2028. These unquoted equity securities are part of an employee incentive scheme and are not intended to be quoted on the ASX, reflecting the company’s strategy to incentivize and retain key personnel.
GenusPlus Group Ltd has announced the issuance of 852,454 Performance Rights to key management personnel and employees under its Employee Securities Incentive Plan. These rights are subject to performance and vesting conditions set by the Board, with potential outcomes including either equity or cash settlements. This move is likely aimed at aligning employee incentives with company performance, potentially impacting shareholder returns and company operations positively.